Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI to Fund Projects Using Patients' Genomes in Clinical Care

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute expects to issue a funding initiative this summer to support pilot demonstration research projects that incorporate patients' genomic information into clinical care.

NHGRI said in a notice yesterday that it plans to fund a consortium of collaborative genomic medicine projects that will demonstrate the feasibility of, and develop methods for, incorporating individual genomic information into their treatment.

The initiative is aimed at expanding current genomic medicine efforts, with an emphasis on collaborative projects in a diverse range of populations and contributing to the available evidence base regarding how genomic information can be used in clinical care. It also seeks to define and disseminate the ways that genomic information is applied and used in treating patients.

The types of genomic information expected to contribute to the efforts include genotypic, sequencing, and family history data, among others.

These pilot studies may involve screening for highly penetrant germline mutations to identify an individual's genetic risks, integrating family history information into electronic medical records, and providing clinical decision support using genomic information.

NHGRI also wants to encourage research that applies pharmacogenomic information in drug selection and dosing, and to use an individual's whole-exome or sequence data for diagnosis and treatment.

The initiative will use the Research Project Cooperative Agreement (U01) code, which supports specified projects in areas representing specific interests and competencies. Such projects do not have a specific funding limit unless it is specified in the funding announcement.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.